These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1183137)

  • 1. Commentary: Patient package inserts. I. Nature, notions, and needs.
    Joubert P; Lasagna L
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):507-13. PubMed ID: 1183137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient package inserts. II. Toward a rational patient package insert.
    Joubert P; Lasagna L
    Clin Pharmacol Ther; 1975 Dec; 18(6):663-9. PubMed ID: 812628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive patient information. A questionnaire study of attitudes, knowledge, and preferred information sources.
    Fleckenstein L; Joubert P; Lawrence R; Patsner B; Mazzullo JM; Lasagna L
    JAMA; 1976 Mar; 235(13):1331-6. PubMed ID: 946249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What information for the patient? Large scale pilot study on experimental package inserts giving information on prescribed and over the counter drugs.
    Servizio di Informazione e di Educazione Sanitaria
    BMJ; 1990 Dec; 301(6763):1261-5. PubMed ID: 2271829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate dosage instructions in package inserts.
    Fuchs J; Hippius M
    Patient Educ Couns; 2007 Jul; 67(1-2):157-68. PubMed ID: 17451909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 30-year history of the change in package insert for Japanese pharmaceutical medicines].
    Sasaki K; Kondo T
    Yakushigaku Zasshi; 2004; 39(2):276-85. PubMed ID: 16025649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine.
    Friedman CP; Romeo D; Hinton SS
    Am J Med; 1997 Feb; 102(2A):50-6. PubMed ID: 9217587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug package inserts--varying information for the same medicines].
    Storflor JG; Pettersen LC; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2013 May; 133(9):955-9. PubMed ID: 23652143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward the patient package insert--a survey of physicians and pharmacists.
    Fleckenstein L
    Drug Inf J; 1977; 11(1):23-9. PubMed ID: 10304966
    [No Abstract]   [Full Text] [Related]  

  • 11. The patient's understanding of the oral contraceptive patient package insert.
    Casey FG; Fluitt DM; Wiatt AL
    Mil Med; 1983 Mar; 148(3):276-8. PubMed ID: 6408516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of outpatients' use and needs of patient medicine information leaflets in Thailand.
    Pongpunna S; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2019 Feb; 41(1):141-150. PubMed ID: 30446897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The experience of patients and general practitioners.
    Cartwright A
    J R Soc Med; 1994; 87 Suppl 23(Suppl 23):8-10. PubMed ID: 8064772
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug information for patients: bringing together the messages from prescriber, pharmacist and manufacturer.
    Herxheimer A; Davies C
    J R Coll Gen Pract; 1982 Feb; 32(235):93-7. PubMed ID: 7097632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of private medical practitioners towards package inserts and other drug information sources.
    Joubert PH; Skene D
    S Afr Med J; 1984 Aug; 66(8):306-7. PubMed ID: 6474294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. By the way, doctor. Whenever my doctor prescribes a medication for me, I ask my pharmacist for the package insert describing the drug. However, I often find the information more alarming than helpful. How can supposedly safe drugs have so many side effects?
    Nicholson CR
    Harv Womens Health Watch; 1999 Oct; 7(2):8. PubMed ID: 10534819
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient package insert readability and design.
    Basara LR; Juergens JP
    Am Pharm; 1994 Aug; NS34(8):48-53. PubMed ID: 7942501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of over-the-counter medicines’ information and strategies oriented to the community for improving its access and quality.].
    Armando PD; Moscardó MN; Tenllado MI; Uema SAN
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):248-254. PubMed ID: 30734703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate use of oral drops: perception of health professionals and assessment of package insert information.
    Zaid AN; Al-Ramahi R; Abu Ghoush A
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):854-9. PubMed ID: 21084041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.